Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Md. Sahab Uddin, Md. Tanvir Kabir
Springer eBooks (2019), pp. 91-115
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Combination Drug Therapy for the Management of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Abdullah Al Mamun, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3272-3272
Open Access | Times Cited: 160
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 160
Bioactive Compounds in Oxidative Stress-Mediated Diseases: Targeting the NRF2/ARE Signaling Pathway and Epigenetic Regulation
Muthu Thiruvengadam, Baskar Venkidasamy, Umadevi Subramanian, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 152
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
Tapan Behl, Gagandeep Kaur, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1413-1413
Open Access | Times Cited: 137
Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Rishika Dhapola, Samir Kumar Beura, Prajjwal Sharma, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 62
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease
Md. Sahab Uddin, Devesh Tewari, Gaurav Sharma, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2902-2919
Closed Access | Times Cited: 135
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
Md. Sahab Uddin, Abdullah Al Mamun, Md. Jakaria, et al.
The Science of The Total Environment (2019) Vol. 707, pp. 135624-135624
Closed Access | Times Cited: 132
Circadian and sleep dysfunction in Alzheimer’s disease
Md. Sahab Uddin, Devesh Tewari, Abdullah Al Mamun, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101046-101046
Closed Access | Times Cited: 128
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1267-1267
Open Access | Times Cited: 112
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md. Tanvir Kabir, Md. Sahab Uddin, Mst. Marium Begum, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3519-3535
Closed Access | Times Cited: 106
Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173412-173412
Open Access | Times Cited: 101
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106479-106479
Closed Access | Times Cited: 97
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3506-3518
Closed Access | Times Cited: 95
Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
Chanchal Sharma, Sang Ryong Kim
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1231-1231
Open Access | Times Cited: 94
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Sohanur Rahman, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5858-5858
Open Access | Times Cited: 91
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Sonia Zaman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 1-20
Closed Access | Times Cited: 90
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, et al.
The Science of The Total Environment (2019) Vol. 700, pp. 134836-134836
Closed Access | Times Cited: 81
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 30
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 26
Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration
Md. Sahab Uddin, Md. Farhad Hossain, Abdullah Al Mamun, et al.
The Science of The Total Environment (2020) Vol. 725, pp. 138313-138313
Closed Access | Times Cited: 67
Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 281-303
Closed Access | Times Cited: 63
Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 59
Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
Abdullah Al Mamun, Md. Sahab Uddin, Md. Fahim Bin Bashar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 47
In vivo neuroprotective capacity of a Dunaliella salina extract - comprehensive transcriptomics and metabolomics study
Alberto Valdés, José David Sánchez-Martínez, Rocío Gallego, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s-like neuropathology
Md. Sahab Uddin, Md. Tanvir Kabir, M. M. Rahman, et al.
Journal of Pharmacy and Pharmacology (2020) Vol. 72, Iss. 8, pp. 1001-1012
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top